How Fresenius Kabi Helped Stabilize the U.S. Heparin Supply

Twice in the last two decades, U.S. heparin supply was threatened by serious recalls, production suspensions and near-critical shortages. Both times, Fresenius Kabi played a central role in protecting patient care. [Read More]

Fighting Oncology Drug Shortages

Learn what Fresenius Kabi is doing to help get the right cancer treatments to the right patients at the right time. [Read More]

At Fresenius Kabi, we’re doing More in America.

We focus on putting lifesaving medicines and technologies in the hands of people who care for patients—and on finding solutions to the challenges they face. Our priority is delivering the support caregivers need every day, while also preparing for what they may need next.

Resilience is critical in health care. Hear how Fresenius Kabi is doing more in America to build resilience into the supply chain of care. [Learn more]

Our commitment to more supply, science and support in America is a reason our customers can deliver patient care with more confidence.
Since 2017, Fresenius Kabi has invested nearly $1 billion to expand and modernize advanced U.S. pharmaceutical production and distribution facilities. More than 70% of the units shipped by Fresenius Kabi in the U.S. are drugs listed on the FDA’s Essential Medicines List.1

From vials to ready-to-administer premixed medicines and convenient prefilled syringes, Fresenius Kabi is continuously enhancing its processes, products and packaging to optimize the availability and safe delivery of medicines throughout hospitals and clinics.

Putting confidence within reach. Our people, products and processes are all focused on supporting our customers in America and helping to bring more confidence to clinicians and their patients.

Our 40,000 team members worldwide are dedicated to working together to help find solutions for caregivers and their patients.

What this all means for our U.S. customers is a more reliable supply of the medications patients need and less vulnerability when there are increased supply demands and other disruptions. We invite you to explore more about how Fresenius Kabi is doing More in America to serve you better.

1. 2023 Data on file; https://www.fda.gov/media/143406/download